Development of a novel 18F-labeled radiotracer targeting granzyme B for imaging early tumor responses to immunotherapy
Background
Immunotherapy has emerged as a promising avenue for malignant tumors treatment, but methods to validate its in vivo antitumor activity remain limited. Granzyme B, a key mediator of immune-mediated cell death, is a potential biomarker for as…